American Association of Kidney Patients Awards Fresenius Medical Care Caregivers with its Highest Honor for Health Care Professionals
Business Wire - Mon Mar 21, 8:00AM CDT
Fresenius Medical Care North America (FMCNA), the continent's leading provider of kidney care products and services, and the American Association of Kidney Patients (AAKP), announced today that AAKP has presented its 2016 Medal of Excellence Award to four FMCNA caregivers at the Renal Physicians Association Annual Meeting in Chandler, Arizona, the highest number of awards for a single organization.
FMS: 42.57 (-0.32)
NxStage Medical Grows but Expects No Profit for 2016
Dan Caplinger, The Motley Fool - Motley Fool - Wed Feb 10, 11:18AM CST
Image source: NxStage Medical. Home dialysis specialist NxStage Medical has made a huge change in how patients get the treatment they need, offering an alternative to the outpatient services that Fresenius Medical Care and other providers...
NXTM: 14.26 (-0.01), FMS: 42.57 (-0.32)
Interface Biologics Announces the Extension of its Licensing Agreement with Fresenius Medical Care
Marketwired - Tue Feb 09, 6:31AM CST
Interface Biologics Inc. (IBI), a privately held commercial stage developer of transformative biomedical-polymer products, is pleased to announce that Fresenius Medical Care (FRANKFURT : FME)(NYSE: FMS), the worlds' largest integrated provider of dialysis products and services, has extended their exclusive licensing agreement for use of Endexo(TM) technology in chronic dialysis systems to cover the acute dialysis market (including CRRT).
FMS: 42.57 (-0.32)
Amgen Tops on Q4 Earnings & Revenues, Ups 2016 Outlook
Arpita Dutt - Zacks Investment Research - Fri Jan 29, 8:05AM CST
Amgen's (AMGN) fourth quarter results were better-than-expected with products like Enbrel, Kyprolis, Sensipar, Prolia, and Xgeva driving growth.
GILD: 91.32 (+1.24), AMGN: 149.24 (+0.48), FMS: 42.57 (-0.32), CELG: 100.54 (+0.62)
MedAssets' Shareholders Approve Takeover by Pamplona
Zacks Equity Research - Zacks Investment Research - Fri Jan 15, 1:50PM CST
MedAssets (MDAS) recently announced the approval of the previously considered merger agreement with Pamplona Capital Management, a specialist investment manager, by its shareholders.
EXAC: 18.52 (+0.16), FMS: 42.57 (-0.32), MDAS: 31.35 (+0.01), ARAY: 5.40 (-0.03)